<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh17168-bib-0013">
 <label>13</label>
 <mixed-citation publication-type="miscellaneous" id="bjh17168-cit-0013">
  <string-name>
   <surname>Camilleri</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Cuadrado</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Phillips</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Wilson</surname>
   <given-names>W</given-names>
  </string-name>, 
  <string-name>
   <surname>Jenner</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Pang</surname>
   <given-names>G</given-names>
  </string-name>, et al. 
  <article-title>Thrombotic microangiopathy in myeloma patients treated with frontline carfilzomib on the phase 2 CARDAMON Trial</article-title>. 
  <year>2020</year>. [cited 2020 August 6]. Available from: EHA Open Access Library EHA25 e‚Äêposter presentations; EP 1018.
 </mixed-citation>
</ref>
